4.6 Review

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D

Prashant Singh et al.

Summary: Fecal microbiota transplantation is an effective strategy to correct microbial dysbiosis in diarrhea-predominant irritable bowel syndrome. For patients with IBS-D, FMT with antibiotic pretreatment significantly reduces bacterial engraftment.

GUT MICROBES (2022)

Article Gastroenterology & Hepatology

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation

Magdy El-Salhy et al.

Summary: This study investigated the factors affecting the response to fecal microbiota transplantation (FMT) in irritable bowel syndrome (IBS) patients. The results showed that male patients and those with low fecal Alistipes levels are most likely to not respond to FMT treatment.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Microbiology

Multi-Time-Point Fecal Sampling in Human and Mouse Reveals the Formation of New Homeostasis in Gut Microbiota after Bowel Cleansing

Mingyang Li et al.

Summary: This study found that the structure and composition of intestinal microbiota changed significantly after bowel cleansing, but the internal structure remained similar to that before cleansing. The most significant changes in microbiota occurred on day 3 after cleansing. Bacteroides, Roseburia, Eubacterium, and Bifidobacterium were identified as the most significantly changed bacteria before and after cleansing.

MICROORGANISMS (2022)

Article Medicine, General & Internal

The biodiversity dose-response curve translates theory and practice from ecological restoration into research and clinical priorities for fecal microbiota transplantation

Matthew R. R. Orr

Summary: The beneficial effects of gut microbiota have led to efforts in cultivating healthy gut flora for disease treatment. The field of ecological restoration may be applicable to microbe restoration in the gut. Common language can lower barriers to interdisciplinary insights. The concept of a biodiversity dose-response curve is introduced to translate ideas from ecological restoration into research and clinical priorities for fecal microbiota transplantation (FMT).

FRONTIERS IN MEDICINE (2022)

Review Chemistry, Medicinal

Commercially Available Enteric Empty Hard Capsules, Production Technology and Application

Ales Franc et al.

Summary: There is a growing demand for enteric capsules that can protect acidic-sensitive substances from the stomach's acidic environment. These capsules, made from pH-soluble or gelling polymers, can encapsulate drugs or biological suspensions and gradually release them in the digestive tract.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases

Gianluca Ianiro et al.

Summary: Our study on the dynamics of microbiome engraftment after FMT and its association with clinical variables uncovered species-specific patterns and presented machine learning models able to predict donors and optimize microbial engraftment.

NATURE MEDICINE (2022)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial

Tom Holvoet et al.

Summary: Fecal microbiota transplantation (FMT) therapy has shown promising efficacy in treating patients with treatment-resistant Irritable Bowel Syndrome (IBS), particularly in relieving predominant bloating symptoms. The treatment response was associated with higher microbiome diversity in stool samples before FMT administration, suggesting a potential biomarker for patient selection.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

Josbert J. Keller et al.

Summary: Faecal microbiota transplantation is gaining attention as an emerging therapeutic option, with stool banks being established within European regulatory frameworks to provide an important treatment choice for patients.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Article Immunology

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Tarek Mazzawi et al.

Summary: The study aimed to investigate the effects of fecal microbiota transplantation (FMT) on the densities of enteroendocrine cells in the duodenum of IBS patients. Results showed significant improvement in symptoms and increased neurogenin 3 stem cell densities after FMT, while Musashi 1 densities remained unchanged. Different types of enteroendocrine cell densities changed significantly after 3 weeks of FMT.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Gastroenterology & Hepatology

Current status of fecal microbiota transplantation for irritable bowel syndrome

Magdy El-Salhy et al.

Summary: Fecal microbiota transplantation (FMT) shows promise in treating IBS, with the efficacy appearing to be donor-dependent. Factors such as dose, route of administration, and frequency of FMT also play a role in influencing treatment outcomes. Further research is needed to explore the impact of these factors on FMT efficacy in IBS patients.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Review Medicine, General & Internal

The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease

Magdalena Stojek et al.

Summary: The exact pathogenesis of inflammatory bowel disease is not fully understood, but it is believed to involve genetic predisposition, environmental triggers, and exaggerated immune responses. Current management strategies focus on correcting immune responses, with potential new treatments like FMT showing promising results.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy

Frederik Cold et al.

Summary: Encapsulated faecal microbiota transplantation (FMT) is an effective and safe treatment for recurrent Clostridioides difficile infection (rCDI), with cure rates comparable to other delivery methods. Despite variations in donor screening, preparation, and treatment protocols, encapsulated FMT remains effective in treating rCDI.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Review Nutrition & Dietetics

Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

Lin Wang et al.

JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2020)

Review Gastroenterology & Hepatology

Microbiome and Its Role in Irritable Bowel Syndrome

Mark Pimentel et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

Kanchana Myneedu et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)

Review Medicine, General & Internal

Fecal microbiota transplantation beyond Clostridioides difficile infections

Koen Wortelboer et al.

EBIOMEDICINE (2019)

Article Gastroenterology & Hepatology

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Olga C. Aroniadis et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Medicine, Research & Experimental

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

Bruno K. Rodino-Janeiro et al.

ADVANCES IN THERAPY (2018)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation for managing irritable bowel syndrome

Magdy El-Salhy et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

Alexander C. Ford et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Review Medicine, General & Internal

Fecal transplantation for treatment of inflammatory bowel disease

Aamer Imdad et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Gastroenterology & Hepatology

Consensus report: faecal microbiota transfer - clinical applications and procedures

J. Koenig et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Review Infectious Diseases

Close association between intestinal microbiota and irritable bowel syndrome

W. -T. Fan et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)

Article Gastroenterology & Hepatology

European consensus conference on faecal microbiota transplantation in clinical practice

Giovanni Cammarota et al.

Review Gastroenterology & Hepatology

Can fecal microbiota transplantation cure irritable bowel syndrome?

Sofie Ingdam Halkjaer et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis

S. P. Costello et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating

Tamar Ringel-Kulka et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)

Article Gastroenterology & Hepatology

Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease

Byron P. Vaughn et al.

INFLAMMATORY BOWEL DISEASES (2016)

Review Gastroenterology & Hepatology

Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives

Hyun Ho Choi et al.

CLINICAL ENDOSCOPY (2016)

Article Infectious Diseases

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection

Caroline Zellmer et al.

INFECTIOUS DISEASES AND THERAPY (2016)

Article Gastroenterology & Hepatology

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

Colleen R. Kelly et al.

GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

Tina Didari et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children

S. Sha et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Review Gastroenterology & Hepatology

Review article: the economic impact of the irritable bowel syndrome

C. Canavan et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Medicine, General & Internal

Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection

Ilan Youngster et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Neurosciences

Gut Microbes and the Brain: Paradigm Shift in Neuroscience

Emeran A. Mayer et al.

JOURNAL OF NEUROSCIENCE (2014)

Editorial Material Medicine, General & Internal

A Clinician's Primer on the Role of the Microbiome in Human Health and Disease

Sahil Khanna et al.

MAYO CLINIC PROCEEDINGS (2014)

Article Gastroenterology & Hepatology

Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine

Lekha Saha

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, General & Internal

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

Els van Nood et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Meeting Abstract Gastroenterology & Hepatology

Follow-up Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Refractory Irritable Bowel Syndrome (IBS)

David Pinn et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Letter Gastroenterology & Hepatology

Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?

Faming Zhang et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Rebecca M. Lovell et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Gastroenterology & Hepatology

Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome

A. C. Ford et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Review Gastroenterology & Hepatology

Postinfectious Irritable Bowel Syndrome

Robin Spiller et al.

GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

The placebo effect in irritable bowel syndrome trials: a meta-analysis

SM Patel et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2005)

Article Gastroenterology & Hepatology

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR

E Malinen et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)

Review Gastroenterology & Hepatology

Bacteriotherapy using fecal flora - Toying with human motions

TJ Borody et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)